These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. [Inhibition of harmaline induced tremor by L-threo-3, 4-dihydroxyphenylserine, an L-norepinephrine precursor]. Yamazaki M, Ikeda Y, Ishikawa M, Inagaki C, Tanaka C. Nihon Yakurigaku Zasshi; 1976 Apr; 72(3):363-9. PubMed ID: 986992 [Abstract] [Full Text] [Related]
24. Improvement in freezing phenomenon of Parkinson's disease after DL-threo-3, 4-dihydroxyphenylserine. Ogawa N, Kuroda H, Yamamoto M, Nukina I, Ota Z. Acta Med Okayama; 1984 Jun; 38(3):301-4. PubMed ID: 6431755 [Abstract] [Full Text] [Related]
25. DL-threo-DOPS as a precursor of noradrenaline. Reches A, Jackson-Lewis V, Fahn S. Naunyn Schmiedebergs Arch Pharmacol; 1985 Nov; 331(2-3):202-8. PubMed ID: 3937060 [Abstract] [Full Text] [Related]
28. Reversal by L-threo-3,4-dihydroxyphenylserine (L-threo-DOPS), a L-norepinephrine precursor of reserpine- or tetrabenazine-induced hypothermia. Katsuyama M, Kato T, Karai N, Nakamura M, Katsube J. Arch Int Pharmacodyn Ther; 1986 Sep; 283(1):61-70. PubMed ID: 3099671 [Abstract] [Full Text] [Related]
29. Improved orthostatic tolerance in familial amyloidotic polyneuropathy with unnatural noradrenaline precursor L-threo-3,4-dihydroxyphenylserine. Carvalho MJ, van den Meiracker AH, Boomsma F, Man in 't Veld AJ, Freitas J, Costa O, de Freitas AF. J Auton Nerv Syst; 1997 Jan 12; 62(1-2):63-71. PubMed ID: 9021651 [Abstract] [Full Text] [Related]
30. DL-3,4-threo-DOPS in Parkinson's disease: effects on orthostatic hypotension and dizziness. Birkmayer W, Birkmayer G, Lechner H, Riederer P. J Neural Transm; 1983 Jan 12; 58(3-4):305-13. PubMed ID: 6420517 [Abstract] [Full Text] [Related]
31. Treatment of dialysis-induced hypotension with L-threo-3,4-dihydroxyphenylserine. Iida N, Tsubakihara Y, Shirai D, Imada A, Suzuki M. Nephrol Dial Transplant; 1994 Jan 12; 9(8):1130-5. PubMed ID: 7800213 [Abstract] [Full Text] [Related]
32. Determination of D,L-threo-3,4-dihydroxyphenylserine and of the D- and L-enantiomers in human plasma and urine. Boomsma F, van der Hoorn FA, Man in 't Veld AJ, Schalekamp MA. J Chromatogr; 1988 Jun 03; 427(2):219-27. PubMed ID: 3137237 [Abstract] [Full Text] [Related]
33. Effect of L-threo-3,4-dihydroxyphenylserine on muscle sympathetic nerve activities in Shy-Drager syndrome. Kachi T, Iwase S, Mano T, Saito M, Kunimoto M, Sobue I. Neurology; 1988 Jul 03; 38(7):1091-4. PubMed ID: 3133573 [Abstract] [Full Text] [Related]
36. Preferential decarboxylation of L-threo-3,4-dihydroxyphenylserine in rat renal tissues. Soares-da-Silva P. Gen Pharmacol; 1993 Jan 03; 24(1):75-81. PubMed ID: 8482506 [Abstract] [Full Text] [Related]